The purified recombinant dUTPase proteins used in these studies were stored at 80C until further use. == ELISA assay == ELISAs were performed essentially as described previously [Lai et al., 2012]. These results suggest that screening of patients sera for the presence of various combinations of anti-dUTPase antibodies could be used as potential biomarkers to help identify/distinguish patients with these syndromes and better direct treatment. Keywords:Chronic Fatigue Syndrome, Epstein-Barr computer virus, Human herpesvirus 6, varicella-zoster computer virus, deoxyuridine triphosphate nucleotidohydrolase, antibodies == Introduction == Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is usually a chronic multisystem illness of unconfirmed etiology [Institute of Medicine, 2015]. In over half of cases, ME/CFS onset is usually associated with acute flu-like symptoms [Klimas et al., 2015]. There are multiple reports in the literature suggesting a role for viruses, particularly human herpesvirus-6 (HHV-6) [Ablashi et al., 2000;Komaroff, 2006;Chapenko et al., 2012] and Epstein-Barr computer virus (EBV) [Cameron et al., 2010;Loebel et al., 2014] in ME/CFS. However, the data concerning a causal relationship between a computer virus and ME/CFS has not been conclusively exhibited and remains a challenge because of the heterogeneity of the patient population and the realization of possibly multiple etiologies. Surprisingly, none of these studies have approached the possibility that computer virus encoded proteins rather than the Aumitin viruses themselves may act as drivers of/contribute to the pathophysiological alterations observed in a subset of patients with ME/CFS. Approximately one-third of the veterans returning from the Operation Desert Storm conflict, were afflicted with a chronic multisystem disorder known as Gulf War Illness (GWI) [Fukuda et al., 1998]. Characterized Aumitin by severe and debilitating symptoms including fatigue, musculoskeletal pain and Rabbit Polyclonal to ADA2L cognitive problems, GWI has no known remedy and requires long-term treatment and monitoring [Eisen et al, 2005]. Multiple hypotheses regarding the etiology of these symptoms soon emerged, as these servicemen were subjected to a number of potentially hazardous conditions, including infectious brokers, medical prophylaxis, pesticides, depleted uranium, oil well fire smoke, chemical and biological warfare brokers and psychological stressors [Steele et al., 2012]. GWI cases exhibit a significant overlap in symptoms with ME/CFS, which include long-term fatigue, sleep disturbances or non-restorative sleep, as well as immune and cognitive dysfunction [Whistler et al., 2009;Institute of Medicine, 2013;Parkitny et al., 2015]. There are currently no validated biomarkers for definitive diagnosis of either syndrome. Thus, there is an urgent need to identify triggers and drivers of ME/CFS and GWI and to understand the molecular mechanisms by which they contribute Aumitin to the development or progression of these illnesses so more efficient diagnostic tools and effective therapeutics can be developed. We have previously demonstrated that this deoxyuridine triphosphate nucleotidohydrolase (dUTPase) encoded by EBV, HHV-6 and VZV possess novel immunoregulatory functions by triggering the activation of toll-like receptor (TLR) 2, which leads to the activation of NF-B and subsequent modulation of downstream genes involved in chronic inflammation, effector T-cell function and neurotransmitter function [Glaser et al., 2006;Ariza et al., 2009,2013,2014]. We Aumitin have also shown that this EBV-encoded dUTPase is usually secreted in exosomes, which function as intracellular messengers, induces the secretion of the pro-inflammatory TH1/TH17 cytokines, alters T- and NK cell functionin vitro, and induces stress and sickness behavior in mice [Padgett et al., 2004;Aubrecht et al., 2014]. Perhaps more importantly, was the obtaining of prolonged and significantly elevated neutralizing antibodies against Aumitin the EBV-encoded dUTPase, which inversely correlated with ME/CFS symptomology in a small subset of patients with ME/CFS [Lerner et al., 2012]. In this study, we examined, using a newly developed ELISA assay, longitudinal samples from a cohort of patients with ME/CFS enrolled in the Good Day Bad Day study and single serum samples from other cohorts of patients diagnosed with GWI or ME/CFS as well as gender, age and ethnicity matched controls. The samples were examined for the presence of IgG antibodies against the.
The purified recombinant dUTPase proteins used in these studies were stored at 80C until further use
- by eprf